(Q37140372)

18 August 2017

Bringing diagnostic technologies to the clinical laboratory: Rigor, regulation, and reality (English)

1 reference

18 August 2017

0 references

Gordon Whiteley

1

1 reference

18 August 2017

1 January 2008

1 reference

Proteomics - Clinical Applications

18 August 2017

1 reference

18 August 2017

2

1 reference

18 August 2017

10-11

1 reference

18 August 2017

1378-1385

1 reference

Systematic review: gene expression profiling assays in early-stage breast cancer

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Proteomics as a tool for biomarker discovery

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

QA/QC issues to aid regulatory acceptance of microarray gene expression data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Intelligent bioprocessing for haemotopoietic cell cultures using monitoring and design of experiments.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Diagnostics and biomarker development: priming the pipeline

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Introduction to the Food and Drug Administration (FDA) regulatory process

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Serum protein markers for early detection of ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Food and Drug Administration regulation of in vitro diagnostic devices

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Biomarker amplification by serum carrier protein binding

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Osteopontin as a potential diagnostic biomarker for ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Use of proteomic patterns in serum to identify ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Gene expression profiling predicts clinical outcome of breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Serum proteomic patterns for detection of prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Preanalytical influences in clinical proteomic studies: raising awareness of fundamental issues in sample banking.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Putting the "bio" back into biomarkers: orienting proteomic discovery toward biology and away from the measurement platform.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

Roche's microarray tests US FDA's diagnostic policy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660881

The mismeasurement of science

3 September 2018

1 reference

12 December 2020

Adenomatous polyposis coli and translational medicine

1 reference

12 December 2020

Translating basic discoveries into better health care: the APM's recommendations for improving translational research

1 reference

12 December 2020

Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer

1 reference

12 December 2020

Running before we can walk?

1 reference

12 December 2020

Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice?

1 reference

12 December 2020

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

1 reference

12 December 2020

Identifiers

DOI

10.1002/PRCA.200780170

1 reference

18 August 2017

1 reference

PMC publication ID

2660881

18 August 2017

PubMed publication ID

19325937

1 reference

PMC publication ID

2660881